Loading...
Thursday April 4, 2024- MIT Sloan Health Systems Initiative Lunch Series with Carl Berke, PhD
E62-450
100 Main Street, Cambridge, MA United States
84
Registered
Registration
Registration is now closed (this event already took place).
Details
Location: E62-450
Time: 11:30am - 1pm
Lunch will be provided in person.
Join Zoom Meeting
Password: 100
The pace of discovery in the life sciences is driving economic growth and public interest in the biomedical sector like never before. Venture capital transforms Invention and discovery from academia into product innovations that improve our health. The high risks associated with early stage investment are managed through the portfolio approach. The reality is that a minority of successes must pay for the majority of failures. There is often more to be learned from the scrutiny of failure than the acceptance of success -this session will cover a case vignettes from my own portfolio that illustrate how best laid plans go wrong. Due diligence investigation only covers the known unknowns but the assessment of risk should reach beyond the limits of anyone’s personal experience and benefit from the mistakes of others.
Carl Berke, PhD
He has more than 25 years of experience in the practice and management of innovation to bring new technologies from lab to market.
A Partner at Mass General Brigham Ventures and has more than 25 years of experience in the practice and management of innovation to bring new technologies from lab to market. As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical products for both consumer and professional markets – he is an inventor on six U.S. patents. He served as a Partner at Integral/Analysis Group, a consulting firm focusing on the management of innovation and growth strategy for clients in healthcare and consumer products. He has been an active private equity investor as a member of Angel Healthcare Investors LLC and is a founder of Mass Medical Angels.
Carl currently holds board roles for InStride Health, Pykus Therapeutics and SeQure Dx. He is a also currently a Board observer for Rippl Care, Tuesday Health, CardioSight and Lyndra Therapeutics and previously held board roles at Annovation [anesthetic agent], Combinent [women’s health], InfoBionic [cardiac monitoring], Kasalis [robotics], LifeImage [diagnostic image sharing], QPID Health [bioinformatics], Quosa [research literature management software], Sebacia [dermatology], Syntimmune [immunotherapy], and the Sudanese Education Fund [philanthropy].
Carl holds an A.B. degree from Cornell University and a PhD in Organic Chemistry from the University of California at Berkeley. He also served as a Lecturer at the MIT Sloan School of Management, teaching various courses on the topic of biomedical enterprise.
Food Provided
Speakers
Carl Berke, PhD
Partner
Mass General Brigham Ventures
https://www.linkedin.com/in/carl-berke/
Experienced biotech and digital health venture investor, with more than 25 years’ experience in the practice and management of innovation to bring new technologies from lab to market.
Carl holds an A.B. degree from Cornell University and a PhD in Organic Chemistry from the University of California at Berkeley. He also served as a Lecturer at the MIT Sloan School of Management, teaching various courses on the topic of biomedical enterprise.
Anne Quaadgras
Director
MIT Sloan Health Systems Initiative
Anne Quaadgras is the Director of the MIT Sloan Health Systems Initiative and a Senior Lecturer at MIT Sloan.
Her work focuses on health systems transformation, and the role of information technology in supporting that change.
Prior to her doctoral work, Anne was a management consultant for fifteen years, specializing in improving decision-making and investment processes in the chemical, pharmaceutical, and financial services industries.
She holds a Bachelor’s and Master’s degree in chemical engineering from MIT. Anne earned her doctorate in information systems at Boston University, where her dissertation research explored how globally distributed groups of experts recognize and respond to operational problems.
Hosted By
Co-hosted with: Health Systems Initiative (OWNER)
Contact the organizers